Cargando…

Acute coronary syndromes with high thrombotic burden: therapeutic innovations

Antiplatelet agents represent one of the cornerstones of drug therapy for acute coronary syndromes (ACS). In the last decade, the arrival of prasugrel and ticagrelor, faster and more powerful oral platelet receptor P2Y12 inhibitors compared to clopidogrel, significantly improved platelet inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menozzi, Alberto, Caretta, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904081/ https://www.ncbi.nlm.nih.gov/pubmed/33654473 http://dx.doi.org/10.1093/eurheartj/suaa144

Ejemplares similares

Thrombotic thrombocytopenic purpura presenting as acute coronary syndrome
por: Mouabbi, Jason Aboudi, et al.
Publicado: (2016)

Impact of Acute Coronary Syndrome on Clinical Outcomes in Patients With Thrombotic Thrombocytopenic Purpura
por: Khalil, Fouad, et al.
Publicado: (2023)

Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients
por: Liu, Yupeng, et al.
Publicado: (2022)

Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes
por: Byrne, Connie E, et al.
Publicado: (2004)

Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At  the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte  Interactions
por: Sexton, Travis, et al.
Publicado: (2016)

Pushing the Boundaries: Drug-Coated Balloons to Treat a Calcified and Thrombotic Lesion in Acute Coronary Syndrome
por: Cioffi, Giacomo Maria, et al.
Publicado: (2022)

A Review of the Role of the Antiplatelet Drug Ticagrelor in the Management of Acute Coronary Syndrome, Acute Thrombotic Disease, and Other Diseases
por: Tao, Luyuan, et al.
Publicado: (2022)

The household economic burden for acute coronary syndrome survivors in Australia
por: Hyun, Karice K., et al.
Publicado: (2016)

Lower coronary plaque burden in patients with HIV presenting with acute coronary syndrome
por: O'Dwyer, E J, et al.
Publicado: (2016)

Acute Thrombotic Occlusion of Right Coronary and Left Circumflex Coronary Arteries in a Patient with Antiphospholipid Syndrome: Successful Stent Implantation
por: Biceroglu, Serdar, et al.
Publicado: (2010)

Economic burden of illness of acute coronary syndromes: medical and productivity costs
por: Zhao, Zhenxiang, et al.
Publicado: (2011)

High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
por: Androulakis, Emmanuel, et al.
Publicado: (2017)

Economic burden of acute coronary syndrome in South Korea: a national survey
por: Kim, Jinhyun, et al.
Publicado: (2013)

Comparison of Shear Stress–Induced Thrombotic and Thrombolytic Effects Among 3 Different Antithrombotic Regimens in Patients With Acute Coronary Syndrome
por: Kim, Minsuk, et al.
Publicado: (2020)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update
por: Lucà, Fabiana, et al.
Publicado: (2023)

A fractal physics explanation for acute thrombotic occlusion in an apparently healthy coronary artery
por: Tesloianu, Nicolae Dan, et al.
Publicado: (2017)

A Tailored Antithrombotic Approach for Patients with Atrial Fibrillation Presenting with Acute Coronary Syndrome and/or Undergoing PCI: A Case Series
por: Giubilato, Simona, et al.
Publicado: (2022)

Catastrophic Antiphospholipid Syndrome with Severe Acute Thrombotic Microangiopathy and Hemorrhagic Complications
por: Vieregge, Gerardo B., et al.
Publicado: (2013)

Antiphospholipid Syndrome Nephropathy with Acute Thrombotic Microangiopathy after Renal Transplantation
por: Suenaga, Atsuhiko, et al.
Publicado: (2023)

Thrombotic Thrombocytopenic Purpura after Percutaneous Coronary Intervention
por: Lee, Jung-Min, et al.
Publicado: (2006)

Clopidogrel-Induced Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome After Coronary Artery Stenting
por: Manor, Shawn M, et al.
Publicado: (2004)

Acute myocardial infarction due to traumatic coronary artery dissection: conflicts with thrombotic and bleeding pathologies
por: Yoshida, Chiaki, et al.
Publicado: (2023)

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
por: Maitta, Robert W., et al.
Publicado: (2021)

Lombardy diagnostic and therapeutic network of thrombotic microangiopathy
por: Mancini, I., et al.
Publicado: (2022)

Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk Scores
por: Natsuaki, Masahiro, et al.
Publicado: (2018)

High-density lipoprotein cholesterol as a therapeutic target for residual risk in patients with acute coronary syndrome
por: Ozaki, Yuichi, et al.
Publicado: (2018)

Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
por: Moisi, Mădălina Ioana, et al.
Publicado: (2020)

Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications
por: Wang, Haiming, et al.
Publicado: (2020)

Therapeutic Efficacy and Safety of Safflower Injection in the Treatment of Acute Coronary Syndrome
por: Lu, Qiang, et al.
Publicado: (2021)

Systemic Immune-Inflammation Index: A Novel Predictor of Coronary Thrombus Burden in Patients with Non-ST Acute Coronary Syndrome
por: Özkan, Uğur, et al.
Publicado: (2022)

Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infection
por: Denham, Christopher, et al.
Publicado: (2019)

Prevention and Management of the Post-Thrombotic Syndrome
por: Makedonov, Ilia, et al.
Publicado: (2020)

Prevention and treatment of the post‐thrombotic syndrome
por: ten Cate‐Hoek, Arina J.
Publicado: (2018)

Clinical Management of Thrombotic Antiphospholipid Syndrome
por: Tumian, Nor Rafeah, et al.
Publicado: (2022)

Current Toolset in Predicting Acute Coronary Thrombotic Events: The “Vulnerable Plaque” in a “Vulnerable Patient” Concept
por: Emfietzoglou, Maria, et al.
Publicado: (2023)

Acute thrombotic occlusion involving three coronary arteries. A unique association with COVID‐19 pneumonia
por: Habib, Mhd Baraa, et al.
Publicado: (2023)

Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura
por: Katsivalis, Katherine V., et al.
Publicado: (2021)

The Challenge of High Coronary Thrombotic Events in Patients with ST-Segment Elevation Myocardial Infarction and COVID-19
por: Anghel, Larisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_72upi227fvjgu2qukiats88tsa